Menu

New solutions and opportunities for 21ST century companies

LISBON INVESTOR CONFERENCE

Lisboa is currently at the heart of the innovation and entrepreneurship ecosystem, supported by highly skilled and motivated companies, professionals and educational institutions.

The first day of the conference is promoted by the Family Businesses Association. Called Growth Day, it will address the theme of finance to companies, traditional solutions vs. new alternatives.

The second day will be promoted by Hovione Capital. Called Health Startup Day, it will be dedicated to startups and investors focused on health care innovation.

When?

November 7th and 8th

Museum of the Orient, Lisbon

BUY TICKETS

9h45 |

Masterclass: Financing alternatives and the Advisory Role
José Lemos, Partner, Clearwater International
Rita Barosa, CEO, Alantra Portugal

10h15 |

Debt – The Classic Alternative
Case Study: Alantra Private Debt with Luis Felipe Castellanos.

10h35 |

Case Study

10h45 |

Coffee Break and Networking

11h00 |

Mezzanine – Accelerate Growth

Daniel Viana, Partner Oxy Capital

11h20 |

Case Study: Respol, Resinas, SA

Filipa Barreto, Associate Partner KPMG

11h30 |

Private Equity – New shareholders to Growth
Marco Lebre, Partner, Crest Capital Partners
João Coelho Borges, Partner, Magnum Capital Industrial Partners

Case Study: Solzaima with Nuno Sequeira

12h00 |

Case Study: Solzaima
Nuno Sequeira, CEO Solzaima

12h45 |

Buffet Lunch and Networking

14h00 |

Taxes – The Eternal Variable
Michael A. Santos, Partner, KPMG.
Filipa Barreto, Associate Partner, KPMG.

14h30 |

Masterclass: Corporate Governance – Governing the Family and the Business
Duarte Pitta Ferraz, Nova SBE
João Talone, Partner Magnum Capital Industrial Partners

15h15 |

Round Table: Corporate Governance

Moderator: Duarte Pitta Ferraz

João Talone, Magnum Capital Industrial Partners

Manuel Champalimaud, Presidente Grupo Manuel Champalimaud

16h00 |

Coffee Break and Networking

16h15 |

Interview with Diane Villax, Hovione
By Alexandra Abreu Loureiro, partner of the reputational consultant Brunswick Group

17h00 |

Closure: Conference
Conclusions by Peter Villax

17h15 |

Drinks & Networking

20h00 |

Lisbon Investor Conference Dinner
Keynote Speaker: Garrett McNamara, surfer of the great wave of the Nazareth Cannon.
Ingredients for success: courage, preparation and teamwork.

The speakers

João

Talone

João Talone, founder and partner of Magnum Capital in 2006, was CEO of EDP and Vice President of HydroCantábrico and Special Government Commissioner.

Marcos

Lagoa

Marcos Lagoa is a board director at Family Business Association. He was chairman and CEO of Resiquímica. He is also a mentor at StartUp Sintra.

Pedro

Siza Vieira

Pedro Siza Vieira is a Portuguese lawyer and politician. From October 2017 to October 2018 he was Minister Assistant to the Prime-Minister, and he is currently, Assistant Minister to the Prime-Minister and Minister of Economy of the Portuguese Government.

Filipa

Barreto

KPMG Associate Partner holds a Management Degree, a postgraduate degree in Corporate Finance and a Master’s degree in Finance from ISCTE. She has over a decade and a half of experience in the M&A market and currently serves in KPMG’s Deal Advisory area.

Alexandra

Abreu Loureiro

Alexandra Abreu Loureiro is partner at the Brunswick Group, a reputation consulting group which leads in Portugal and in the Portuguese-speaking world.

Gonçalo

Mendes

Gonçalo Mendes, partner at Oxy Capital, focuses on financing and implementing Oxy Capital II, an investment vehicle for growth and capital replacement in Portuguese companies. He is a member of the Supervisory Board of Nova SBE University and has gone through organizations such as ECS Capital, Millennium Global Investments and McKinsey & Company.

Diane

Villax

Diane Villax is Founder Chairman of Hovione, a company she founded in 1959 with her husband, Ivan Villax. Hovione is a worldwide company with a large experience in the development and compliant manufacture of Active Pharmaceutical Ingredients and Drug Product Intermediates.

Daniel

Viana

Daniel Viana has been a partner of Oxy Capital since its founding in 2012. Oxy Capital is a private equity fund management company with over one billion euros under management. He is currently dedicated to investing in the Oxy Capital II Fund which seeks to invest in Portuguese SMEs with high growth potential. He was previously Associate Director at UBS Investment Bank in New York and has an MBA from Harvard Business School.

Garrett

McNamara

Garrett McNamara is a giant wave explorer, renowned for discovering and pioneering when surfing the world’s largest wave in Nazareth. Since then he has shared his experience as a leader.

Luis

Castellanos

Managing Partner at Alantra has over 25 years of experience in debt transaction structuring and asset management. Prior to joining Alantra in 2014, he was a partner at PwC, responsible for debt advisory practice in Spain. In the past he was a director at European Capital and worked in this same area at BNP Paribas Iberia, New York and Paris.

José

Lemos

José Lemos is a founding partner at Clearwater International. Among others he was founder and executive director of CBI (Investment Bank) and president of the Lisbon Stock Exchange.

João

Bento

João Bento has been CEO of CTT since May 2019. He is also a member of the General Council of the University of Lisbon, Vice President of the Academy of Engineering, member of the Strategic Innovation Council of Vieira de Almeida and member of the General Council of the Portuguese Institute of Corporate Governance. .

Rita

Barosa

Rita Barosa is CEO of Alantra, a Spanis global mid-market specialist, nominated in 2019 for “European Corporate Finance House of The Year”. She also worked at Grupo Espírito Santo as advisor to the Board of Directors.

Duarte

Pitta Ferraz

Governance & Finance Professor at NOVA SBE and CEO of IVENS, Governance Advisors. Doctorate in Business Administration. ROC and non-executive director of the European Investment Bank, Infrastructures of Portugal, EuroBIC and Manuel Champalimaud Group. Has publications in scientific journals about Governance. Member of the Harvard Business Review advisory board.

Marco

Lebre

Marco Lebre, partner at Crest Capital Partners, founded Explorer Investments in 2002, where he was dedicated to private equity. Today he is also a visiting professor at Católica University.

Nuno

Sequeira

Nuno Sequeira is the CEO of Solzaima. Solzaima, a renewable energy equipment company, national leader in biomass solutions. He is also a partner at Singularity Capital.

João

Coelho Borges

João Coelho Borges is a partner at Magnum Capital. He work in private equity at Och-Ziff Capital Management in London and also worked at Goldman Sachs. He is currently president of ROQ and Board Member of Vendap, INDIBA and Aire Networks.

Michael

Santos

Michael Santos studied Organization and Business Management at ISCTE. He is Partner, Corporate and International Tax at KPMG, which provides audit, tax and advisory services

Peter

Villax

Peter Villax is currently Chairman of Hovione Capital, a VC firm focused on investing in life sciences’ projects across Europe. Peter is the President of the Portuguese Family Business Association and Board Member of the European Family Businesses Federation.

Interested?

View the agenda | Buy Tickets

Learn more about the

Agenda

Friday. November 8th

HEALTH STARTUP DAY

08h30 |

Registration, Networking and Welcome Coffee

09h00 |

Opening of the Conference
Welcome Remarks – Peter Villax, Chairman Hovione Capital
Conference Outline – Ricardo P. Henriques, Conference Chairman & CEO Hovione Capital

09h20 |

Keynote Session: Why this is a great time to invest in life sciences in Portugal.

09h35 |

Keynote session: Portugal: Right choice, Right time to invest in Life Sciences
Luís Castro Henriques, President of AICEP, Portugal Global – Trade & Investment Agency

09h40 |

Therapeutics Time: Presentations by SolasCure, Immunethep and CellmAbs

09h50 |

Masterclass: How to raise capital from VCs: the winning way.
Dirk Kersten, General Partner at Forbion (NL)

10h10 |

Coffee Break e Networking

10h40 |

200M Fund: co-investment in innovative Portuguese startups
Marco Fernandes, CEO at PME Investimentos, leading the new 200M Co-Investment Fund.

10h50 |

EIT Health: accelerating Healthcare innovation in Europe
Nuno Viegas, Business Creation Director at EIT Health Innostars (NL).

11h00 |

Therapeutics Time: Presentations by BSIM Therapeutics and Asgard Therapeutics

Jury Members
Lev Osherovich, Versant Ventures (CH)
Daniela Couto, Biogeneration (NL)
Giovanni Mariggi, Medicxi (UK)
Jonathan Tobin, Arix Biosciences (UK)
Pablo Cironi, Caixa Capital Risc (ES)

12h15 |

Buffet e Networking

13h30 |

Biotech in Europe: Scaling Innovation
Jorge Santos da Silva, Partner at McKinsey & Co (CH)

13h45 |

SRS Advogados: Life Sciences & Healthcare Legal Practice
Ana Menéres, Partner.

13h50 |

Panel – What do corporates and startups need from each other?
Moderated by David Cristina, Fosun Healthcare (UK)

Richard Davis, Johnson & Johnson Innovation (UK)
Khatereh Ahmadi, Merck Sharp & Dohme (UK)
Jorge Santos da Silva, McKinsey & Co (CH)
Gonçalo Andrade, Nanoform (FI)

14h30 |

Keynote Session:

Keynote Session: Lymphact: How we went from the lab to a successful exit.
Prof. Bruno Silva Santos, Institute of Molecular Medicine, University of Lisbon, Founder

14h50 |

Coffee Break e Networking

15h20 |

Digital Health Time: Digital is transforming Healthcare
Presentations by Mediceus, Performetric and Tonic App

15h55 |

MedTech Time: Presentations by Adapttech, Delox, GlyCardial Diagnostics, EIT Health Headstart Fund Winner #1 and #2

Jury Members:
David Malta, Vesalius (LU)
João Ribas, Novo Holdings (DK)
José Mesa, Alta Life Sciences (ES)
Peter Dines, Mercia Asset Management PLC (UK)

16h45 |

Closure:
Peter Villax, Chairman da Hovione Capital

16h50 |

Drinks e Networking

18h00 |

Event Closing

Meet Health Startup Day Startups

Adapttec
logo@2x
logo-mini-blanco
Logótipo-Ficheiro
Asgard Therapeutics
CellmAbs Biopharmaceutics
logo_name-6e6bbaeae309ccd06dedc6203f71912f214d51db5d3419d54a37a07967242272
tonicapp_logo_site
logoPequeno1
vaxdyn-logo-640x452
BSIM Therapeutics
Mediceus
Proterris_final_rgb_LOGO226x48

The speakers

Bruno

Silva-Santos

Prof. Bruno Silva-Santos is an Associate Professor at the Faculty of Medicine of the University of Lisbon and Principal Investigator at João Lobo Antunes Molecular Institute of Medicine in Lisbon.

Luís

Castro Henriques

Luís Castro Henriques is Chairman & CEO of AICEP – Portuguese Trade & Investment Agency. Previously, he was Executive Board Member of AICEP, since 2014, responsible for investment (Loans, Grants & Tax Benefits), financial management and corporate relations.

David

Cristina

Executive Director at Fosun International, a leading Chinese conglomerate, where he currently leads the Healthcare Investment team for Europe. He has over 10 years of experience in venture creation, VC and PE experience across US, EU and China. He was on the board of Lymphact, Immunethep and Tonic App.

Rick

Davis

Rick is Senior Director, New Ventures and Transactions, Oncology at Johnson & Johnson Innovation in London. In this role, Rick leverages his experience and knowledge of the scientific and biotech landscape to identify and evaluate external opportunities and deliver transformative innovation into the pipeline.

Gonçalo

Andrade

Chief of Business Operations at Nanoform. Gonçalo is a Biochemist by training and has over 20 years’ experience in the pharmaceutical and venture capital industries.

Peter

Dines

Peter joined Mercia Asset Management PLC (UK) in 2015 as Head of Life Sciences & Biosciences. He is currently responsible for investing in new companies in the life sciences sector, with over 20 years’ experience. In addition became Chief Operating Officer in 2018.

Dirk

Kersten

Dirk Kersten is a General Partner at Forbion and focuses primarily on new investments. Dirk was previously a Partner at Gilde Healthcare, where he led their Boston/US operations.

José António

Mesa

Jose Mesa is a Partner at Alta Life Sciences where he invests in drug development and medical devices. Jose was previously Investment Director at Caixa Capital Risc where he lead analysis, negotiation and structuring of investments in life sciences companies.

Jorge

Santos da Silva

Jorge Santos da Silva is a Partner at McKinsey where he leads the Biotech and Biosimilars practice. His areas of expertise are commercial and marketing strategy, launch and M&A. He previously had a successful academic career in science, especially in neurology/neuroscience.

João

Ribas

João Ribas joined Novo Seeds in 2018 as an Investment Associate. Previously, he was an analyst at M Ventures. Among other activities, he started several new ventures in the USA and Europe.

Jonathan

Tobin

Jonathan Tobin is an Investment Director at Arix Bioscience where he specializes in biotechnology investments. He currently sits on the board of Artios Pharma, Atox Bio and Mitoconix Bio.

Khatereh

Ahmadi

Khatereh is Executive Director and Oncology Search and Evaluation Lead at Merck Sharp & Dohme in London. Previously, Khatereh advised several Biotechs and led several M&A and licensing deals.

Giovanni

Mariggi

Giovanni is a Partner at Medicxi and has been with the firm since its inception in 2016. Prior to Medicxi, Giovanni was a Principal at Index Ventures for four years, having joined in 2012.

Pablo

Cironi

Pablo is the Director of Life Science Investment Funds at Caixa Capital Risc. He currently serves on the Board of Medlumics, Aelix Therapeutics, Minoryx Therapeutics, iProteos, Proteodesign and Sanifit.

David

Malta

David Braga Malta is a Venture Partner at Vesalius Biocapital. He previously founded NeurIMM, Cell2B and BoostPharma, where he serves(ed) as a manager. He was previously a member of Caixa Capital’s venture capital team.

Marco

Fernandes

Marco Fernandes is currently CEO of PME Investimentos, leading the new 200M Coinvestment Fund and Social Innovation Fund management teams. Previously was Director of DNA Cascais and CEO of Portugal Ventures

Daniela

Couto

Daniela Couto is a Principal at Biogeneration Ventures. Daniela is the managing director of Staten Biotech and serves on the board of Catalym. Daniela previously was CEO at Cell2B, a life sciences company that she co-founded dedicated to treat immune and inflammatory diseases.

Daniela

Seixas

MD, PhD, MBA, co-founder & CEO of Tonic App, a digital health startup. Built her clinical and academic career for more than 17 years before joining this venture.

Peter

Villax

Peter Villax is currently Chairman of Hovione Capital, a VC firm focused on investing in life sciences’ projects across Europe. Peter is the President of the Portuguese Family Business Association and Board Member of the European Family Businesses Federation.

Ricardo

Perdigão Henriques

Ricardo Perdigão Henriques is the CEO of Hovione Capital, a healthcare-specialized VC fund based in Portugal investing in early-stage life sciences projects across Europe.

Lev

Osherovich

Lev is Director of Innovation and Sourcing at Versant Ventures where he identifies and evaluates early-stage drug discovery projects, bridging academic and industry knowledge to uncover unexpected therapeutic opportunities.

Get to know our partners

labiotech_logo_lic
kpmg_logo_lic
aicep_logo_lic
aicep_logo_lic
patentree logo lic
ivity_bc_lic
SRS-Advogados-logo SITE
Telles Logo
AON_Site_LIC
PME INVESTIMETOS
Millennium BP LOGO SITE
Canon_site
vwr_logo_site
Previous
Next

Interested?

View the agenda | Buy Tickets

Menu

© All rights reserved – Empresas Familiares

Powered by Hora Comunicação

Terms and Conditions